CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder

Overview of attention for article published in PLOS ONE, January 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

patent: 9 patents

Citations

dimensions_citation: 116 Dimensions

Readers on

mendeley: 105 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Gene therapy for treating Mucopolysaccharidosis type II

Grant US-11819539-B2

United States of America

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS…

Grant US-11613739-B2

United States of America

Methods for purification of arysulfatase A

Grant US-11407984-B2

United States of America

Gene therapy for treating mucopolysaccharidosis type II

Grant US-11253612-B2

United States of America

ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

Application US-20210369871-A1

United States of America

Delivery of therapeutic compounds to the brain and other tissues

Grant US-11040088-B2

United States of America

Glucocerebrosidase gene therapy for Parkinson's disease

Grant US-10967073-B2

United States of America

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS…

Application US-20200149019-A1

United States of America

TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2…

Application EP-2793933-A4

European Patent Office